Welcome to Accelerō® Bioanalytics.
Company Overview
A new star is born, a new light in the sky of bioanalytics: Accelerō® Bioanalytics. Inspired by expert knowledge. Old hands at work. We are committed to become a preferred partner in bioanalytical services for the nucleic acids biotechnology and pharmaceutical industry. Accelerō® Bioanalytics realizes the idea of a novel business model which is unique throughout Europe.
Accelerō® now is a registered trademark of Accelerō Bioanalytics, Berlin.
How can we Accelerate Your Drug Development?
Don´t waste time to develop bioanalytical methods which we already might provide. Experience the advantages. All from a single source. In 2010 we have been dealing with quantitative bioanalytics for more than 10 years. Our services range from hybridization assays to Real-Time RT-qPCR to detect your investigational new drug based on nucleic acids chemistry (RNA/DNA). We also offer immunology assays to investigate immune response to nucleic acids therapeutics. Certainly all of these are fully compliant to Good Laboratory Practice (GLP) regulations.
A Stitch in Time Saves Nine: Contact Us Today!
Thank you very much for visiting our website. If you would like to learn more about our services, please don´t hesitate to contact us at any time. You are always welcome. The fastest way to us: this way please ...
News
- LPT Pharm Tox (Hamburg, Germany) Partnered for Collaboration Agreement
- GLP Compliant Applied Biosystems ViiA™ 7 Dx qPCR System Acquired
- Accelero Bioanalytics Transformed into Limited Liability Company (GmbH)
- Accelero Bioanalytics Acquires Biotek Synergy Multimode Plate Reader
- EuroTIDES 2011 Supported by Accelerō Bioanalytics
